Home / Recalls / Lannett Company, Inc. / D-1508-2020

D-1508-2020 Class II Terminated

Recalled by Lannett Company, Inc. — Philadelphia, PA

Recall Details

Product Type
Drugs
Report Date
August 26, 2020
Initiation Date
August 10, 2020
Termination Date
July 22, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, Manufactured by: Tianjin Tianyao Pharmaceuticals Co., Ltd No. 221 Huanghai Road, Tianjin Economical-Technological Development Area, Tianjin, China 300457 NDC 0527-2931-37

Reason for Recall

Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg

Distribution Pattern

US Nationwide

Code Information

Batch Number PE190701e1 with expiry June 2021

Other recalls by Lannett Company, Inc.

  • D-0096-2026 Class II — Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, (October 10, 2025)
  • D-0642-2025 Class II — Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate a (August 19, 2025)
  • D-0599-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distrib (August 11, 2025)
  • D-0112-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, D (October 25, 2024)
  • D-0161-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 (November 9, 2022)
  • D-0160-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 (November 9, 2022)
  • D-0558-2022 Class II — Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and (February 9, 2022)
  • D-0630-2020 Class I — Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Dist (December 6, 2019)
  • D-0309-2020 Class II — Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distr (October 28, 2019)
  • D-0996-2019 Class III — Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, D (February 21, 2019)